EU Panel Backs Drugs for Hypoglycemia, Osteoporosis EU Panel Backs Drugs for Hypoglycemia, Osteoporosis
After an initial no, CHMP backs romosozumab for severe osteoporosis with high fracture risk; Baqsimi is the first nasally administered treatment for severe hypoglycemia.International Approvals
Source: Medscape Med Students Headlines - Category: Universities & Medical Training Tags: Diabetes & Endocrinology News Alert Source Type: news
More News: Diabetes | Endocrinology | Orthopaedics | Osteoporosis | Students | Universities & Medical Training